1. Corticosteroids are widely administered to oxygenated COVID-19 patients
    Ronald Chavin Ronald Chavin United States says:
    October 3, 2021 at 12:04 AM

    Corticosteroids are widely administered to oxygenated COVID-19 patients without any evidence that they reduce LONG-TERM mortality.  Of the 60% of all studies for corticosteroids that showed a health benefit at around Day 28, none of them compared the survival of the corticosteroid group versus the placebo group at say, Day 90.  Corticosteroids worsen diabetes for pre-existing diabetics and trigger diabetes in non-diabetics, even if they are not positive for COVID-19:
    https://pubmed.ncbi.nlm.nih.gov/34470529/
    https://pubmed.ncbi.nlm.nih.gov/33634148/
    journals.sagepub.com/doi/10.1177/1076029621993573
    https://www.medscape.com/viewarticle/942375
    www.dailymail.co.uk/.../...ems-research-shows.html
    journals.plos.org/.../journal.pone.0249481
    www.ncbi.nlm.nih.gov/pmc/articles/PMC7722522/
    www.news-medical.net/.../...9-say-researchers.aspx
    www.nature.com/.../1
    www.ncbi.nlm.nih.gov/pmc/articles/PMC7885705/

    Yes, the SARS-CoV-2 virus can worsen or trigger diabetes too.

    Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback